Melanotan II, 10mg, (Lyophilized Powder),$49.00,N/A,99% HPLC,Research use only. Not for human or veterinary use.

Melanotan II, 10mg, (Lyophilized Powder),$49.00,N/A,99% HPLC,Research use only. Not for human or veterinary use.

$40.00 USD
Sale price  $40.00 USD Regular price 
Skip to product information
Melanotan II, 10mg, (Lyophilized Powder),$49.00,N/A,99% HPLC,Research use only. Not for human or veterinary use.

Melanotan II, 10mg, (Lyophilized Powder),$49.00,N/A,99% HPLC,Research use only. Not for human or veterinary use.

$40.00 USD
Sale price  $40.00 USD Regular price 

What is Melanotan 2?

Melanotan 2 (frequently abbreviated as MT-2) is a synthetic, laboratory-created peptide. It is an analog of the naturally occurring alpha-melanocyte-stimulating hormone, the hormone responsible for stimulating melanin production in the human body.

 

First developed in the 1980s by researchers at the University of Arizona, the peptide was originally conceptualized as a medical intervention. The initial goal was to promote a protective, sunless tan in people with fair skin, thereby reducing their risk of developing skin cancer from ultraviolet (UV) exposure. Today, however, its clinical development has largely stalled, and it is predominantly known for its widespread, unregulated use within the fitness, bodybuilding, and tanning communities.

Mechanism of Action

To understand how Melanotan 2 works, it helps to look at its interaction with the body's melanocortin system. MT-2 acts as a non-selective agonist of several melanocortin receptors in the body—specifically MC1, MC3, MC4, and MC5.

 

  • Pigmentation (MC1 Receptor): When the peptide binds to the MC1 receptor, it strongly stimulates melanogenesis. This is the biological process where melanocytes (skin cells) produce melanin, the dark pigment responsible for skin color. By artificially triggering this system, MT-2 causes the skin to darken rapidly, often requiring only minimal exposure to UV light to achieve a deep tan.


     

  • Appetite and Libido (MC4 Receptor): Unlike some other peptides, Melanotan 2 can cross the blood-brain barrier. Once there, it binds to the MC4 receptor, which plays a major role in regulating feeding behavior and sexual function. Consequently, MT-2 is known to cause appetite suppression and significantly increased libido, including spontaneous erections in men.


     

Note: Because of its combined effects on tanning, weight, and sexual arousal, the peptide was colloquially dubbed the "Barbie drug" by the media in the early 2000s.

 

Risks and Side Effects

While the prospect of a quick tan and increased libido is appealing to its users, Melanotan 2 carries a heavy side-effect profile and significant medical risks.

 

Short-term side effects frequently reported immediately following an injection include severe nausea, facial flushing, lethargy, headaches, and spontaneous, sometimes painful, erections (priapism).

 

However, the long-term and more severe risks are of much greater concern to the medical community:

  • Skin Abnormalities: MT-2 causes the rapid and uneven darkening of existing moles, freckles, and nevi. There are ongoing clinical concerns and several case reports linking the unregulated hyper-stimulation of melanocytes to the development or masking of melanoma (skin cancer), which directly contradicts the peptide's original developmental intent.


     

  • Cardiovascular Strain: Some users have reported cardiovascular issues, including elevated blood pressure and rapid heart rate.

  • The Dangers of the Grey Market: MT-2 is typically administered via subcutaneous injection. Because it is an unapproved substance, users must purchase it online as a "research chemical." This unregulated grey market exposes users to massive risks, including mislabeled vials, contaminated compounds, toxic fillers, and bloodborne infections resulting from improper, at-home injection techniques.


     

Regulatory Status

Despite decades of existence, Melanotan 2 has never been approved by the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), or any other major global health authority for human use. The clinical trials required to prove its safety and efficacy were largely abandoned years ago due to its unacceptable side effects.